跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial
Approved
STANDARD
ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ba8a9a880ea86277
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
ba8a9a880ea86277
Product Name
ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial
Artg Id
96636
Artg Name
ETOPOSIDE EBEWE etoposide 50mg/2.5mL injection vial
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2005-08-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ba8a9a880ea86277
Type
Standard
Back to TGA Approvals
